Clinical Trials for Dogs with Cancer: What Every Pet Owner Needs to Know

A cancer diagnosis in a beloved dog is one of the hardest moments a pet owner faces. Between processing the diagnosis and researching treatment options, many owners never hear about one of the most promising avenues available: veterinary clinical trials.

Clinical trials can offer dogs access to treatments that are more advanced than what's available through standard veterinary care — and in many cases, the treatment is provided at little or no cost. Here's a thorough guide to understanding how clinical trials work for dogs with cancer, and how to find out if your dog is eligible.

Why Dogs, Specifically?

Dogs develop cancer spontaneously, just like humans, and many canine cancers share striking biological similarities with their human counterparts. Canine lymphoma is genetically close to human non-Hodgkin's lymphoma. Canine osteosarcoma mirrors the disease in adolescent humans. Canine bladder cancer resembles human muscle-invasive bladder cancer.

This makes dogs uniquely valuable research subjects — not as stand-ins for humans in a laboratory, but as patients who benefit directly from the research while also generating data that can help both dogs and humans in the future. As a result, the veterinary clinical trial ecosystem for dogs is large and well-funded, with major universities across the U.S. actively recruiting.

Which Cancers Have the Most Active Trials?

While trials exist for over 39 cancer types, the most active areas of research for dogs as of 2026 include the following.

Lymphoma is the most studied canine cancer. Trials explore CAR-T cell therapy, novel checkpoint inhibitors, oral kinase inhibitors, and combination protocols. Multiple fully funded studies are currently recruiting.

Osteosarcoma is bone cancer that is aggressive and heartbreaking. Current trials include vaccine-enhanced T-cell therapy, autologous cancer vaccines combined with checkpoint inhibitors, and limb-sparing surgical protocols paired with novel biologics.

Hemangiosarcoma is one of the most devastating diagnoses — and one of the most active research fronts. Trials include liquid biopsy studies for early detection and small molecule inhibitor combinations alongside standard chemotherapy.

Bladder cancer, also known as transitional cell carcinoma, is being actively targeted by CDK9 inhibitors and other novel drugs in fully funded trials. Dogs with TCC are strong candidates given the biological parallels with human urothelial carcinoma.

Mast cell tumor trials are exploring receptor tyrosine kinase inhibitors and immunotherapy combinations for dogs at various grades.

Several trials also target canine oral tumors including melanoma and squamous cell carcinoma with novel drugs and immunotherapy approaches, including some that are fully funded.

NK cell immunotherapy and other novel approaches are in active trials for soft tissue sarcoma in dogs.

What Makes a Dog Eligible?

Each trial has its own inclusion and exclusion criteria, but some general eligibility factors apply across most studies.

Factors that typically help eligibility include a confirmed diagnosis with a pathology report, a specific cancer type, grade, or stage that matches the trial's target population, a dog that is generally healthy enough to undergo treatment with acceptable organ function, and no or limited prior treatments, as some trials specifically want treatment-naïve patients.

Factors that may disqualify include prior exposure to certain drug classes the trial is studying, concurrent serious health conditions such as heart disease or severe kidney disease, age or weight outside the trial's parameters, and cancer that has progressed to a stage not covered by the protocol.

The most important step is to simply run your dog's profile through a matching system — eligibility criteria are complex enough that there's no substitute for a direct comparison against each open trial.

What Does the Process Look Like?

Once you've identified a potential trial through Pet Trial Finder, here's what typically happens.

Step 1 — Referral: We generate a confidential referral to the university research team, forwarding your pet's relevant details to the appropriate contact.

Step 2 — Screening Visit: The research team reviews your dog's records and typically schedules an initial screening visit to confirm eligibility. This may involve bloodwork, imaging, or a physical exam.

Step 3 — Enrollment: If your dog qualifies and you decide to proceed, you sign an informed consent document and enrollment begins. The team walks you through every aspect of the protocol — timeline, required visits, monitoring, and what to watch for at home.

Step 4 — Treatment: Your dog receives the investigational therapy. This might be an injection, an oral medication, a surgical procedure, or infusion — depending on the trial. Visits are more frequent than standard care, which means more eyes on your dog throughout.

Step 5 — Monitoring and Follow-Up: After the active treatment phase, monitoring continues. The research team tracks response, watches for late effects, and collects the data that makes the trial scientifically meaningful.

How Far Will You Need to Travel?

This is one of the most practical concerns for owners. Trials are conducted at veterinary teaching hospitals, and the 25 institutions in Pet Trial Finder's network are spread across the country — but they're not in every city.

We recommend checking your home state first, as many large states have a major veterinary university with active trials. Consider the trial's visit schedule, since some protocols require only monthly visits while others are more intensive. It's also worth asking the research team whether telemedicine or local vet monitoring can substitute for any visits.

For high-priority trials, many families have found the distance worthwhile — particularly when the treatment is fully funded and represents a meaningful improvement over available standard care.

The Honest Conversation About Outcomes

Clinical trials are not guaranteed cures. Some trials will show benefit; some will not. This is the nature of research.

What you can expect is that your dog will receive meticulous, expert care throughout. You'll understand exactly what the treatment is intended to do and what the known risks are. You can withdraw your dog at any time. And regardless of the research outcome, your dog's participation contributes to improving treatment for future dogs with the same diagnosis.

For many owners, the decision to enroll is as much about the quality of care and access to innovation as it is about outcome. The level of specialist attention a trial dog receives is genuinely difficult to replicate in standard practice.

How Much Does a Clinical Trial Cost for a Dog?

Fully funded trials cover the experimental drug, imaging, all specialist visits, and monitoring — meaning nothing trial-related falls to you. Partially funded trials cover the investigational drug and key diagnostics, with some standard-care components potentially applying. Fee-for-service trials, which are uncommon in our database, provide trial oversight only with all costs applying.

For context, treating canine osteosarcoma with standard amputation and chemotherapy typically runs $8,000 to $15,000. A fully funded osteosarcoma trial covers the novel therapy entirely, with some also covering standard-of-care components.

How to Find a Clinical Trial for Your Dog

The fastest way is to use Pet Trial Finder's search tool at www.pettrialfinder.com. Enter your dog's diagnosis, age, and prior treatment history and we match against every open trial in our database across 25 universities in seconds.

You can also ask your vet or veterinary oncologist, as they may be aware of trials at nearby institutions and can provide the diagnostic records the research team will need.

Checking directly with veterinary universities in your region is another option — most major vet schools publish their open trials on their websites, though the information can be fragmented and hard to navigate. Pet Trial Finder aggregates all of this into one place, updated in real time.

Frequently Asked Questions

Can my dog stay on their current medication during a trial? It depends on the trial. Some protocols require a washout period from prior medications; others allow concurrent treatment. Always disclose all current medications during the screening process.

What if my dog lives far from a trial site? Ask the research team about their flexibility. Some allow local vet monitoring for certain visits. For others, the travel may be necessary — and for many families, it's been worthwhile.

Will my regular vet be kept in the loop? Yes. Most research teams coordinate with your primary vet and can provide updates throughout the trial. Your regular vet remains part of your dog's care team.

What happens if my dog's cancer progresses during the trial? The research team monitors for this closely. If a dog is not responding or is worsening, the protocol allows for withdrawal and transition to other care options. Participation never locks you in.

Pet Trial Finder connects dogs and cats with cancer to active clinical trials at accredited U.S. veterinary universities — confidential and straightforward. Visit www.pettrialfinder.com to check your pet's eligibility.